Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Messenger | 5 | 2017 | 545 | 1.360 |
Why?
|
| Antidepressive Agents | 4 | 2018 | 78 | 1.170 |
Why?
|
| Protein Biosynthesis | 4 | 2016 | 44 | 1.100 |
Why?
|
| Kv1.1 Potassium Channel | 3 | 2014 | 5 | 1.090 |
Why?
|
| Depressive Disorder, Major | 2 | 2018 | 41 | 1.090 |
Why?
|
| Homeostasis | 2 | 2017 | 137 | 0.980 |
Why?
|
| Receptors, GABA-B | 3 | 2016 | 19 | 0.960 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 20 | 0.960 |
Why?
|
| Neurons | 7 | 2016 | 491 | 0.950 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2018 | 39 | 0.850 |
Why?
|
| Dendrites | 3 | 2015 | 17 | 0.820 |
Why?
|
| Neuronal Plasticity | 4 | 2017 | 86 | 0.780 |
Why?
|
| Hippocampus | 7 | 2018 | 225 | 0.760 |
Why?
|
| Animals | 17 | 2018 | 8544 | 0.600 |
Why?
|
| Exons | 1 | 2018 | 53 | 0.570 |
Why?
|
| Gene Expression | 2 | 2018 | 362 | 0.560 |
Why?
|
| Alcoholism | 1 | 2018 | 103 | 0.530 |
Why?
|
| Sirolimus | 2 | 2014 | 34 | 0.490 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 6 | 0.470 |
Why?
|
| Depressive Disorder | 1 | 2016 | 76 | 0.470 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 7 | 0.470 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 6 | 0.460 |
Why?
|
| Memory | 1 | 2017 | 216 | 0.460 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2015 | 2 | 0.450 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 4 | 0.450 |
Why?
|
| Status Epilepticus | 1 | 2014 | 21 | 0.430 |
Why?
|
| Rats | 9 | 2018 | 1946 | 0.430 |
Why?
|
| Peroxiredoxins | 1 | 2015 | 117 | 0.430 |
Why?
|
| MicroRNAs | 2 | 2014 | 194 | 0.430 |
Why?
|
| Epilepsy | 1 | 2015 | 86 | 0.430 |
Why?
|
| Parkinson Disease | 1 | 2015 | 92 | 0.420 |
Why?
|
| Synapses | 4 | 2018 | 89 | 0.420 |
Why?
|
| Brain | 3 | 2016 | 1031 | 0.410 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 17 | 0.400 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 40 | 0.390 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 129 | 0.370 |
Why?
|
| Proteins | 1 | 2013 | 155 | 0.370 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 526 | 0.360 |
Why?
|
| Potassium Channels | 3 | 2004 | 20 | 0.350 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2002 | 10 | 0.340 |
Why?
|
| Piperidines | 3 | 2018 | 141 | 0.330 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 1118 | 0.280 |
Why?
|
| Phenols | 2 | 2018 | 20 | 0.250 |
Why?
|
| Protein Kinases | 1 | 2006 | 34 | 0.250 |
Why?
|
| Ethanol | 2 | 2018 | 198 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2015 | 923 | 0.240 |
Why?
|
| Cells, Cultured | 4 | 2015 | 887 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2015 | 765 | 0.240 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 125 | 0.240 |
Why?
|
| Stress, Psychological | 2 | 2018 | 233 | 0.220 |
Why?
|
| Mice | 3 | 2015 | 2691 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2015 | 29 | 0.210 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 90 | 0.200 |
Why?
|
| Humans | 7 | 2017 | 34475 | 0.160 |
Why?
|
| Male | 6 | 2018 | 20697 | 0.150 |
Why?
|
| Receptors, Drug | 1 | 1999 | 21 | 0.150 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 60 | 0.150 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2018 | 6 | 0.150 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2018 | 5 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2018 | 34 | 0.140 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 21 | 0.140 |
Why?
|
| Presynaptic Terminals | 1 | 2018 | 40 | 0.140 |
Why?
|
| Social Isolation | 1 | 2018 | 45 | 0.140 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 63 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 1999 | 268 | 0.140 |
Why?
|
| Models, Animal | 1 | 2018 | 198 | 0.140 |
Why?
|
| GABA Agents | 1 | 2017 | 3 | 0.140 |
Why?
|
| Receptors, GABA | 1 | 2017 | 7 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2018 | 121 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 14 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2017 | 207 | 0.130 |
Why?
|
| Comorbidity | 1 | 2018 | 596 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 70 | 0.130 |
Why?
|
| Dopamine | 1 | 2018 | 268 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 834 | 0.120 |
Why?
|
| Autophagy | 1 | 2016 | 56 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2015 | 47 | 0.110 |
Why?
|
| Swimming | 1 | 2015 | 7 | 0.110 |
Why?
|
| Valine | 1 | 2015 | 14 | 0.110 |
Why?
|
| Synaptosomes | 1 | 2015 | 17 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 36 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 46 | 0.110 |
Why?
|
| Kainic Acid | 1 | 2014 | 11 | 0.110 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2014 | 18 | 0.110 |
Why?
|
| Proteomics | 1 | 2015 | 106 | 0.110 |
Why?
|
| Protein Binding | 1 | 2015 | 255 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 77 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2015 | 143 | 0.110 |
Why?
|
| RNA Stability | 1 | 2013 | 4 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 5 | 0.100 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2013 | 1 | 0.100 |
Why?
|
| Immobility Response, Tonic | 1 | 2013 | 1 | 0.100 |
Why?
|
| Action Potentials | 1 | 2014 | 220 | 0.100 |
Why?
|
| GABA Antagonists | 1 | 2013 | 14 | 0.100 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 16 | 0.100 |
Why?
|
| Baclofen | 1 | 2013 | 28 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 50 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 35 | 0.100 |
Why?
|
| Binding Sites | 1 | 2013 | 150 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 148 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 124 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 46 | 0.100 |
Why?
|
| Transfection | 1 | 2013 | 216 | 0.100 |
Why?
|
| Calcium | 1 | 2013 | 343 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 2352 | 0.070 |
Why?
|
| Protein Conformation | 2 | 1999 | 111 | 0.070 |
Why?
|
| Rats, Long-Evans | 2 | 2018 | 92 | 0.070 |
Why?
|
| Sindbis Virus | 1 | 2006 | 3 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 25 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 34 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 91 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 175 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2006 | 264 | 0.060 |
Why?
|
| ras Proteins | 1 | 2004 | 10 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 42 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2004 | 124 | 0.050 |
Why?
|
| Protein Transport | 1 | 2002 | 82 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 319 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 389 | 0.040 |
Why?
|
| Heart | 1 | 2002 | 191 | 0.040 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1999 | 1 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 21 | 0.040 |
Why?
|
| Prolactin | 1 | 1999 | 11 | 0.040 |
Why?
|
| Glycosylation | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 52 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 65 | 0.040 |
Why?
|
| Glutaral | 1 | 1998 | 1 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1998 | 13 | 0.040 |
Why?
|
| Detergents | 1 | 1998 | 18 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1998 | 56 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 17 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1998 | 57 | 0.040 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2018 | 57 | 0.040 |
Why?
|
| Cell Membrane | 1 | 1998 | 111 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2018 | 147 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 438 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1998 | 430 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1262 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 2004 | 1 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 11 | 0.010 |
Why?
|
| Arginine | 1 | 2004 | 23 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 43 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 75 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 34 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 6 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 25 | 0.010 |
Why?
|
| COS Cells | 1 | 2002 | 33 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 16 | 0.010 |
Why?
|
| Endocytosis | 1 | 2002 | 12 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 24 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 62 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 77 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 41 | 0.010 |
Why?
|
| Microtubules | 1 | 2002 | 22 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 80 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 54 | 0.010 |
Why?
|
| Oocytes | 1 | 2002 | 48 | 0.010 |
Why?
|